Routine sensor-augmented pump therapy in type 1 diabetes: The INTERPRET study

Diabetes Technology and Therapeutics

Volumn 15, Issue 4, 2013, Pages 273-280

  Nørgaard, Kirsten ^a   Scaramuzza, Andrea ^b   Bratina, Natasa ^c   Lalić, Nebojsa M ^d   Jarosz Chobot, Przemyslaw ^e   Kocsis, Gyozo ^f   Jasinskiene, Edita ^g   De Block, Christophe ^h   Carrette, Odile ⁱ   Castañeda, Javier ^j   Cohen, Ohad ^k  

^a HVIDOVRE HOSPITAL   (Denmark)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^d UNIVERSITY OF BELGRADE   (Serbia)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

^f Peterfy Hospital   (Hungary)

^g LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^h ANTWERP UNIVERSITY HOSPITAL   (Belgium)

ⁱ Medtronic International Trading SàrL ^*  (Switzerland)

^j MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^k SHEBA MEDICAL CENTER   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CHILD; CLINICAL EFFECTIVENESS; COMPUTER PROGRAM; CONTINUOUS INFUSION; DISEASE DURATION; FEMALE; GLUCOSE SENSOR; GLYCEMIC CONTROL; GROUPS BY AGE; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SENSOR AUGMENTED PUMP THERAPY;

ADOLESCENT; ADULT; AGED; BIOSENSING TECHNIQUES; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; EUROPE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INSULIN INFUSION SYSTEMS; ISRAEL; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84876102886     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0288     Document Type: Article

References (25)

1. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M: Improved glycemic control in poorly controlled patients with type 1 diabetes using realtime continuous glucose monitoring. Diabetes Care 2006;29:2730-2732.
2. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
3. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32:1378-1383.
4. O'Connell MA, Donath S, O'Neal DN, Colman PG, Ambler GR, Jones TW, Davis EA, Cameron FJ: Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: A randomised controlled trial. Diabetologia 2009; 52:1250-1257.
5. Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, Jeandidier N, Nicolino M:Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes. The Real-Trend Study. Diabetes Care 2009;32:2245-2250.
6. Battelino T, Conget I, Olsen B, Schütz-Fuhrmann I, Hommel E, Hoogma R, Schierloh U, Sulli N, Bolinder J; SWITCH Study Group: The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: A randomised controlled trial. Diabetologia 2012; 55:3155-3162.
7. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group: Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311-320.
8. Hermanides J, Nørgaard K, Bruttomesso D, Mathieu C, Frid A, Dayan CM, Diem P, Fermon C, Wentholt IM, Hoekstra JB, DeVries JH: Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled type 1 diabetes; a randomized controlled trial. Diabet Med 2011;28:1158-1167.
9. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, Kollman C, Laffel L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV: Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009;32:1947-1953.
10. Pickup JC, Freeman SC, Sutton AJ: Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self-monitoring of blood glucose: Metaanalysis of randomised controlled trials using individual patient data. BMJ 2011;343:d3805.doi: 10.1136/bmj.d3805.
11. Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, Wolpert H; Endocrine Society: Continuous glucose monitoring: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:2968-2979.
12. Blevins TC, Bode BW, Garg SK, Grunberger G, Hirsch IB, Jovanovi-c L, Nardacci E, Orzeck EA, Roberts VL, Tamborlane WV; AACE Continuous Glucose Monitoring Task Force, Rothermel C: Statement by the American Association of Clinical Endocrinologists Consensus Panel on Continuous Glucose Monitoring. Endocr Pract 2010;16:730-745.
13. Phillip M, Danne T, Shalitin S, Buckingham B, Laffel L, Tamborlane W, Battelino T; Consensus Forum Participants: Use of continuous glucose monitoring in children and adolescents. Pediatr Diabetes 2012;13:215-228.
14. Nørgaard K, Scaramuzza A, Bratina N, Lalić N, Jarosz-Chobot P, Kocsis G, Verkauskiene R, De Block C, Carrette O, Castañeda J, Cohen O; the INTERPRET Study Group: Sensor-augmented pump therapy in real-life: Results of the INTERPRET observational study [A-417-000300183]. Oral presentation at the Advances for Technologies and Treatment of Diabetes (ATTD) 2012 Congress, February 2012, Barcelona, Spain.
15. Nørgaard K, Scaramuzza A, Bratina N, Lalić N, Jarosz-Chobot P, Kocsis G, Verkauskiene R, De Block C, Carrette O, Castañeda J, Cohen O; the INTERPRET Study Group: SAP therapy in real life: Patient-reported outcomes results of the INTERPRET observational study [abstract 1058]. Diabetologia 2012;55(Suppl 1):pS434.
16. Bradley C: The Diabetes Treatment Satisfaction Questionnaire: DTSQ. In: Bradley C, ed. Handbook of Psychology and Diabetes. A Guide to Psychological Measurement in Diabetes Research and Practice. Chur, Switzerland: Harwood Academic Publishers, 1994.
17. Bradley C: The Diabetes Treatment Satisfaction Questionnaire (DTSQ): Change version for use alongside status version provides appropriate solution where ceiling effects occur. Diabetes Care 1999;22:530-532.
18. Gonder-Frederick LA, Schmidt KM, Vajda KA, Greear ML, Singh H, Shepard JA, Cox DJ: Psychometric properties of the Hypoglycemia Fear Survey-II for adults with type 1 diabetes. Diabetes Care 2011;34:801-806.
19. Buse JB, Dailey G, Ahmann AA, Bergenstal RM, Green JB, Peoples T, Tanenberg RJ, Yang Q: Baseline predictors of A1c reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: The STAR 3 experience. Diabetes Technol Ther 2011;13:601-606.
20. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
21. Scaramuzza AE, Iafusco D, Rabbone I, Bonfanti R, Lombardo L, Schiaffini R, Buono P, Toni S, Cherubini V, Zuccotti GV; Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology (ISPED): Use of integrated real-time continuous glucose monitoring/insulin pump system in children and adolescents with type 1 diabetes: A 3-year follow-up study. Diabetes Technol Ther 2011;13:99-103.
22. Danne T, Kordonouri O, Holder M, Haberland H, Golembowski S, Remus K, Blá sig S, Wadien T, Zierow S, Hartmann R, Thomas A: Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump pherapy. Diabetes Technol Ther 2011;13:1129-1134.
23. Garg S, Brazg RL, Bailey TS: Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: The In-Clinic ASPIRE Study. Diabetes Technol Ther 2012;14:205-209.
24. Joubert M, Reznik Y: Personal continuous glucose monitoring (CGM) in diabetes management: Review of the literature and implementation for practical use. Diabetes Res Clin Pract 2011;96:294-305.
25. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Quality-of-life measures in children and adults with type 1 diabetes. Diabetes Care 2010; 33:2175-2177.